Cite
HARVARD Citation
Maiese, K. (2020). Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways. Expert review of clinical pharmacology. 13 (1), pp. 23-34. [Online].